La bourse est fermée

Hologic, Inc. (HOLX)

NasdaqGS - NasdaqGS Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
71,47+0,04 (+0,06 %)
À la clôture : 04:00PM EDT
71,47 0,00 (0,00 %)
Échanges après Bourse : 05:02PM EDT

Hologic, Inc.

250 Campus Drive
Marlborough, MA 01752
United States
508 263 2900
https://www.hologic.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein6 990

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Stephen P. MacMillanChairman, CEO & President4,12M4,73M1964
Ms. Karleen M. ObertonChief Financial Officer1,6M490,44k1970
Mr. Essex D. MitchellChief Operating Officer925,29kS.O.1980
Mr. John M. GriffinGeneral Counsel1,47M948,95k1961
Mr. Jan VerstrekenGroup President of International1,44MS.O.1968
Mr. Paul MalenchiniChief Information OfficerS.O.S.O.S.O.
Ryan M. SimonVice President of Investor RelationsS.O.S.O.S.O.
Mr. Peter P. DunneSenior Vice President of Human ResourcesS.O.S.O.1956
Ms. Monica Aguirre BerthelotVP & Chief of StaffS.O.S.O.S.O.
Mr. Erik S. AndersonDivision President of Breast & Skeletal Health SolutionsS.O.S.O.1982
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Hologic, Inc. en date du 1 juin 2024 est 7. Les scores principaux sont Audit : 7; Société : 7; Droits des actionnaires : 7; Compensation : 6.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.